Advestra Advises Novartis on USD 11.0 Billion Note Placement to Refinance Avidity Acquisition

"Advestra advised Swiss pharma Novartis on the Swiss aspects of a USD 11.0 billion note placement issued in seven tranches (six fixed‑rate, one floating‑rate). The proceeds will refinance Novartis’s acquisition of Avidity Biosciences. The Advestra team included Annette Weber, Thomas Reutter and Valérie Bayard (capital markets) and Céline Martin (tax)."